Last $8.95 USD
Change Today -0.15 / -1.65%
Volume 14.7K
TRNS On Other Exchanges
Symbol
Exchange
NASDAQ GM
As of 4:00 PM 09/17/14 All times are local (Market data is delayed by at least 15 minutes).

transcat inc (TRNS) Snapshot

Open
$9.02
Previous Close
$9.10
Day High
$9.38
Day Low
$8.86
52 Week High
07/29/14 - $10.90
52 Week Low
11/11/13 - $7.24
Market Cap
60.8M
Average Volume 10 Days
10.3K
EPS TTM
$0.51
Shares Outstanding
6.8M
EX-Date
--
P/E TM
17.5x
Dividend
--
Dividend Yield
--
Current Stock Chart for TRANSCAT INC (TRNS)

Related News

No related news articles were found.

transcat inc (TRNS) Related Businessweek News

No Related Businessweek News Found

transcat inc (TRNS) Details

Transcat, Inc. provides calibration, repair, inspection, and compliance services in the United States, Canada, and internationally. The company also distributes professional grade handheld test, measurement, and control instrumentation. It operates through two segments, Service and Distribution. The Service segment offers calibration service on new and used instruments and repair services. This segment also provides compliance services, which comprise analytical qualification, validation, and remediation services, as well as repair, inspection, and consulting services. In addition, it offers CalTrak, a proprietary documentation and asset management system that is used to manage the workflow of its customers’ assets; and CalTrak Online, which provides its customers with Web-based asset management capability, as well as a safe and secure off-site archive of calibration and other service records. The Distribution segment distributes approximately 100,000 test, measurement, and control instruments for customers’ test and measurement instrumentation needs. This segment markets and sells its products through direct catalog marketing, Website and other Web-based advertising, outbound sales, and an inbound call center. The company serves life-science, pharmaceutical, biotechnology, and medical device manufacturing; industrial manufacturing; energy; and chemical manufacturing industries, as well as other industries that require accuracy in their processes and confirmation of the capabilities of their equipment. Transcat, Inc. was founded in 1964 and is headquartered in Rochester, New York.

401 Employees
Last Reported Date: 06/26/14
Founded in 1964

transcat inc (TRNS) Top Compensated Officers

Chief Executive Officer and President
Total Annual Compensation: $322.5K
Chairman of the Board
Total Annual Compensation: $280.0K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $237.6K
Vice President of Marketing
Total Annual Compensation: $247.1K
Compensation as of Fiscal Year 2014.

transcat inc (TRNS) Key Developments

Transcat, Inc. Executes Amendment to Secured Revolving Credit Agreement

Transcat Inc. announced that it has executed an amendment to its $20 million secured revolving credit agreement, increasing the funds available under the amended credit facility to $30 million. The amended credit facility matures on September 20, 2018. Borrowings under the amended credit facility may be used for working capital and acquisitions. Borrowings available for acquisitions increased to $15 million in any fiscal year pursuant to the amended credit facility, compared with the $10 million available under the original credit facility.

Transcat Inc. Agrees to Terms on $1.5 Million Calibration and Compliance Services Contract

Transcat Inc. announced that the company has agreed to terms on a three-year, $1.5 million contract to provide calibration and compliance services to a Life Science company headquartered in the Northeast U.S.

Transcat Inc. Reports Unaudited Consolidated Earnings Results for the First Quarter Ended June 28, 2014; Provides Capital Expenditure Guidance for the Fiscal 2015

Transcat Inc. reported unaudited consolidated earnings results for the first quarter ended June 28, 2014. For the quarter, the company reported net income of $445,000 or $0.06 diluted earnings per share on total revenue of $29,119,000 against net income of $721,000 or $0.09 diluted earnings per share on total revenue of $28,710,000 a year ago. Operating income was $759,000 and income before income taxes was $714,000 against operating income of $1,152,000 and income before income taxes of $1,148,000 a year ago. Net cash used in operating activities was $2,414,000 and purchase of property and equipment was $711,000 against net cash used in operating activities of $505,000 and purchase of property and equipment of $354,000 a year ago. EBITDA was $1,903,000 against $1,168,000 a year ago. The company expects capital expenditures to be in the range of $3 million to $3.5 million in fiscal 2015.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TRNS:US $8.95 USD -0.15

TRNS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Cantel Medical Corp $35.95 USD +0.24
Mesa Laboratories Inc $64.73 USD -1.95
View Industry Companies
 

Industry Analysis

TRNS

Industry Average

Valuation TRNS Industry Range
Price/Earnings 17.6x
Price/Sales 0.5x
Price/Book 2.0x
Price/Cash Flow 16.7x
TEV/Sales 0.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TRANSCAT INC, please visit www.transcat.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.